Electronic Drug Delivery Devices Market To Reach $99.5 Billion By 2030

Electronic Drug Delivery Devices Market Growth & Trends

The global electronic drug delivery devices market size is anticipated to reach USD 99.5 billion by 2030 and is anticipated to grow at a CAGR of 8.14% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing the growing geriatric population and prevalence of chronic diseases, increasing awareness for personalized medicine, rising preference for home healthcare, and the integration of digital technologies. For instance, in June 2024, AptarGroup, Inc. collaborated with SHL Medical to integrate Aptar Digital Health’s SaMD platform with SHL Medical’s advanced drug delivery systems, such as autoinjectors, pen injectors, and specialty delivery systems. 

As patients are increasingly preferring to manage their health conditions at home, there is a growing demand for drug delivery devices that enable safe, effective, and easy at-home treatments. Devices such as insulin pumps, auto-injectors, wearable infusion pumps, and pre-filled syringes are becoming indispensable tools in home healthcare because they allow patients to self-administer medications with minimal assistance, offering both convenience and autonomy. For instance, in October 2023, Victrex plc, known for its innovative PEEK biomaterial solutions, introduced an advanced product, the VICTREX PC101 grade, specifically designed for drug delivery and pharmaceutical contact applications. This launch aligns with the growing trend of utilizing drug delivery devices in homecare environments, enhancing accessibility for patients seeking innovative solutions.

Moreover, technology trends in the electronic drug delivery devices market are rapidly advancing, driven by the need for greater precision, personalization, and patient convenience. Some of the new trends include the integration of digital health technologies, wearable drug delivery devices, and the use of microfluidics. The rise of precision medicine is also driving innovation. The devices are being tailored to the individual’s genetic makeup, condition, or specific therapeutic needs, ensuring better outcomes and fewer side effects.

 Request a free sample copy or view report summary: Electronic Drug Delivery Devices Market Report

Electronic Drug Delivery Devices Market Report Highlights

• Based on product, the implantable drug delivery devices segment dominated the market with the largest revenue share of 33.0% in 2024 owing to reduced side effects, controlled drug release, and their ability to provide localized treatment.

• Based on application, the diabetes segment accounted for the largest revenue share in 2024 due to its high prevalence and growing patient population, technological advancements in diabetes care, growing market demand, and reimbursement support.

• Based on region, North America held the largest revenue share of over 43.4% in 2024. This can be attributed to technological advancements, an increasing prevalence of chronic diseases, and rising demand for patient-centric drug delivery solutions.

Electronic Drug Delivery Devices Market Segmentation

Grand View Research has segmented the global electronic drug delivery devices market based on product, application, and region:

Electronic Drug Delivery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Smart Infusion Pumps (Infusion Systems)

  • Non-biologic Smart Infusion Systems

  • Biologic Smart Infusion Systems

    • Smart Infusion Insulin Pumps

    • Others

• Smart Metered Dose Inhalers (Inhalation Devices)

• Implantable Drug Delivery Devices

  • Biologic Implantable Drug Delivery Devices

  • Non-biologic Implantable Drug Delivery Devices

• Smart Transdermal Patches (Transdermal Delivery Systems)

• Others

Electronic Drug Delivery Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetes

• Respiratory Diseases

• Oncology

• Cardiology

• Others

Electronic Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Electronic Drug Delivery Devices Market:

• Medtronic plc

• Insulet Corporation

• Becton, Dickinson and Company (BD)

• Tandem Diabetes Care, Inc.

• Ypsomed AG

• Novo Nordisk A/S

• Sanofi S.A.

• Eli, Lilly and Company

• AstraZeneca plc

• GlaxoSmithKline plc

• Boehringer Ingelheim International GmbH

• Pfizer, Inc.

• Teva Pharmaceutical Industries

• Phillips-Medisize, LLC

• West Pharmaceutical Services

• Gerresheimer AG

• Nemera Group

• SHL Group

• Owen Mumford

• Haselmeier AG

• ICU Medical

• Hisamitsu Pharmaceutical Co., Inc.

• Sparsha Pharma International

• Baxter International, Inc.

• Fresenius Kabi AG

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Novartis AG

• AptarGroup, Inc.

• Teleflex Incorporated

• Abbott Laboratories